日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hysterectomy Status and Outcomes in Patients With Grade 1, Stage IA Endometrioid Adenocarcinoma

子宫切除术状态及1级IA期子宫内膜样腺癌患者的预后

Jhaveri, Vasanti; Meyer, Larissa; Chen, Lu; Matsuo, Koji; Romero, Roshni P; Khor, Victor; Lin, Yvonne G; Wright, Jason D; Huepenbecker, Sarah P

Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients

对165,912名美国患者的真实世界队列中,癌症治疗的非适应症和非指南使用情况进行系统分析

Liu, Ruishan; Wang, Lisa; Rizzo, Shemra; Garmhausen, Marius Rene; Pal, Navdeep; Waliany, Sarah; McGough, Sarah; Lin, Yvonne G; Huang, Zhi; Neal, Joel; Copping, Ryan; Zou, James

Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial

基因组图谱对新诊断卵巢癌癌症免疫疗法的影响:来自 IMagyn050 随机临床试验的生物标志物分析

Landen, Charles N; Molinero, Luciana; Hamidi, Habib; Sehouli, Jalid; Miller, Austin; Moore, Kathleen N; Taskiran, Cagatay; Bookman, Michael; Lindemann, Kristina; Anderson, Charles; Berger, Regina; Myers, Tashanna; Beiner, Mario; Reid, Thomas; Van Nieuwenhuysen, Els; Green, Andrew; Okamoto, Aikou; Aghajanian, Carol; Thaker, Premal H; Blank, Stephanie V; Khor, Victor K; Chang, Ching-Wei; Lin, Yvonne G; Pignata, Sandro

Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer

一项针对新诊断的III/IV期卵巢癌患者的安慰剂对照随机III期IMagyn050/GOG 3015/ENGOT-OV39试验,评估了阿特珠单抗的总体生存率和患者报告结局。

Pignata, Sandro; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Penson, Richard T; Taskiran, Cagatay; Anderson, Charles; Hietanen, Sakari; Myers, Tashanna; Madry, Radoslaw; Willmott, Lyndsay; Lortholary, Alain; Thomes-Pepin, Jessica; Aghajanian, Carol; McCourt, Carolyn; Stuckey, Ashley; Wu, Xiaohua; Nishio, Shin; Copeland, Larry J; He, Yvette; Molinero, Luciana; Patel, Sheetal; Lin, Yvonne G; Khor, Victor K; Moore, Kathleen N

Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer

卵巢癌中生殖系和体细胞 BRCA 检测的时间模式和应用

Huepenbecker, Sarah P; Wright, Jason D; Downer, Mary K; Incerti, Devin; Luhn, Patricia; Dolado, Ignacio; Bastiere-Truchot, Lydie; Lin, Yvonne G; Chan, John K; Meyer, Larissa A

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

阿特珠单抗、贝伐珠单抗和化疗治疗新诊断的 III 期或 IV 期卵巢癌:安慰剂对照随机 III 期试验 (IMagyn050/GOG 3015/ENGOT-OV39)

Moore, Kathleen N; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Anderson, Charles; Scambia, Giovanni; Myers, Tashanna; Taskiran, Cagatay; Robison, Katina; Mäenpää, Johanna; Willmott, Lyndsay; Colombo, Nicoletta; Thomes-Pepin, Jessica; Liontos, Michalis; Gold, Michael A; Garcia, Yolanda; Sharma, Sudarshan K; Darus, Christopher J; Aghajanian, Carol; Okamoto, Aikou; Wu, Xiaohua; Safin, Rustem; Wu, Fan; Molinero, Luciana; Maiya, Vidya; Khor, Victor K; Lin, Yvonne G; Pignata, Sandro

Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer

在以治愈为目的的宫颈癌患者化疗放疗后序贯使用伊匹木单抗

Mayadev, Jyoti S; Enserro, Danielle; Lin, Yvonne G; Da Silva, Diane M; Lankes, Heather A; Aghajanian, Carol; Ghamande, Sharad; Moore, Kathleen N; Kennedy, Vanessa A; Fracasso, Paula M; Schilder, Russell J

Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)

接受根治性放化疗后,使用伊匹木单抗治疗的局部晚期宫颈癌患者的免疫激活(GOG-9929)

Da Silva, Diane M; Enserro, Danielle M; Mayadev, Jyoti S; Skeate, Joseph G; Matsuo, Koji; Pham, Huyen Q; Lankes, Heather A; Moxley, Katherine M; Ghamande, Sharad A; Lin, Yvonne G; Schilder, Russell J; Birrer, Michael J; Kast, W Martin

Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response

复杂非典型增生中的内质网应激可能是隐匿性癌和孕激素反应的预测因子

Tierney, Katherine E; Ji, Lingyun; Dralla, Shannon S; Yoo, Eunjeong; Yessaian, Annie; Pham, Huyen Q; Roman, Lynda; Sposto, Richard; Mhawech-Fauceglia, Paulette; Lin, Yvonne G

Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer

采用白蛋白结合型紫杉醇和拓扑替康的双重节拍化疗方案对卵巢癌具有强大的抗血管生成活性

Previs, Rebecca A; Armaiz-Pena, Guillermo N; Lin, Yvonne G; Davis, Ashley N; Pradeep, Sunila; Dalton, Heather J; Hansen, Jean M; Merritt, William M; Nick, Alpa M; Langley, Robert R; Coleman, Robert L; Sood, Anil K